Launch at a Global Scale from India.

India—often called “the world’s pharmacy”—combines unmatched scale in vaccine and API production with rapidly growing biologics and digital-health ecosystems anchored in Hyderabad’s Genome Valley, Bengaluru’s Biotech Corridor, and other thriving clusters.

Leasing that works for you

We work with you to structure the right lease that serves your needs

Who We Serve.

• Global and domestic pharmaceutical companies scaling clinical or commercial production.

• Public and private research institutes driving next-generation biologics.

• Leading universities advancing translational science and talent development.

Why India?

• Incentives that matter – multi-year Production-Linked Incentive (PLI) schemes for APIs, key starting materials and high-value drugs, plus dedicated funds for common-facility build-outs.

• R&D tax benefits – 100 % deduction for qualifying in-house scientific research expenses.

• Trusted national regulator – CDSCO approvals recognised by major markets, underpinned by WHO-prequalified vaccine leadership.

• Deep talent pool – 300 000+ life-science graduates each year and a growing bench of digital-biotech experts in AI-enabled drug discovery.

• Strategic location & cost edge – competitive operating costs and seamless access to Asia-Pacific, EMEA and North-American supply chains.

Let’s Propel Discovery—Together.

From green-field builds to capacity expansions and collaborative labs, our team stands ready to make your India strategy seamless. Connect with us today to see how we can power your next breakthrough.